Sensus Healthcare, Inc.
For the period ended Jun 30, 2025. Filed Aug 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 12, 2025
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2025-03-31; filed 2025-05-15.
0001753926-25-000853
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosureCurrent report: 10-Q
Period ended 2025-06-30; filed 2025-08-12.
0001753926-25-001290
Item 1A. Risk FactorsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 11 previous paragraphs and 2 current paragraphs.
2 unchanged; 0 reworded; 0 added; 9 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 4 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Removed paragraphs (9)
Previous report
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Previous report
There were no unregistered sales of securities during the three months ended March 31, 2025.
Previous report
In August 2023, the Company’s Board of Directors authorized a program to purchase up to $3,000,000 of shares of the Company’s common stock. Purchases may be made from time to time in a variety of methods, including open market purchases, depending upon market conditions, including the market price of the common stock, and other factors. The program (i) does not obligate the Company to acquire any particular amount of its common stock, (ii) has no time limit, and (iii) may be modified, suspended, or discontinued at any time at the Company’s discretion.
Previous report
The following table contains information about all purchases made during the three months ended March 31, 2025 by, or on behalf of, us and any affiliated purchaser (as defined in Rule 10b-18(a)(3) under the Exchange Act) of shares or other units of any class of our equity securities that is registered pursuant to Section 12 of the Exchange Act.
Previous report
Item 3. Defaults Upon Senior Securities